Safety and efficacy of ferric derisomaltose and its effect on blood transfusions in women with severe anaemia from heavy menstrual bleeding
Hong Kong Journal of Gynaecology, Obstetrics and Midwifery · 2023
DOI: 10.12809/hkjgom.23.2.338 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hong Kong Journal of Gynaecology, Obstetrics and Midwifery, 2023. Verfasst von Caryssa Ling Yan und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
This study investigates the safety and efficacy of ferric derisomaltose (FDI) and its effect on blood transfusion requirements in women with severe anaemia secondary to heavy menstrual bleeding (HMB).
Methods
Medical records of women aged ≥18 years who were admitted to Tuen Mun Hospital with severe iron deficiency anaemia (a haemoglobin level of
Zitieren
APA
Yan, C. L., Young, B. R., Shek, J. W. N., & So, P. L. (2023). Safety and efficacy of ferric derisomaltose and its effect on blood transfusions in women with severe anaemia from heavy menstrual bleeding. Hong Kong Journal of Gynaecology, Obstetrics and Midwifery. https://doi.org/10.12809/hkjgom.23.2.338
Vancouver
Yan CL, Young BR, Shek JWN, So PL. Safety and efficacy of ferric derisomaltose and its effect on blood transfusions in women with severe anaemia from heavy menstrual bleeding. Hong Kong Journal of Gynaecology, Obstetrics and Midwifery. 2023. doi:10.12809/hkjgom.23.2.338
BibTeX
@article{Yan2023,
author = {Yan, Caryssa Ling and Young, Benjamin Ross and Shek, Jade Wing Ngan and So, Po Lam},
title = {Safety and efficacy of ferric derisomaltose and its effect on blood transfusions in women with severe anaemia from heavy menstrual bleeding},
journal = {Hong Kong Journal of Gynaecology, Obstetrics and Midwifery},
year = {2023},
doi = {10.12809/hkjgom.23.2.338}
}
EUVIMED